Product image of Iqymune (Human Normal Immunoglobulin) supplied by GNH India

Iqymune

Active Ingredient:
Human Normal Immunoglobulin
Origin:
EU

Iqymune (Human Normal Immunoglobulin)

Human Normal Immunoglobulin, the active ingredient in Iqymune, is an immunoglobulin presented as a sterile intravenous solution for infusion use. It provides passive immunity by supplying normal human antibodies and is employed when patients have insufficient or defective immunoglobulin production, such as in primary or secondary immune deficiencies or autoimmune conditions.

GNH India supplies Iqymune as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and clinics worldwide and research institutions across Europe, Asia and the Americas with consistent quality.

Manufacturer / TM Owner

Laboratoire Francais Du Fractionnement Et Des Biotechnologies

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Iqymune, a human normal immunoglobulin preparation, is used in several immune‑related conditions to restore antibody levels and modulate immune activity.

  • Primary immunodeficiency diseases: restores protective antibody levels, reducing infection frequency.
  • Secondary immunodeficiency (e.g., chronic lymphocytic leukemia): supplements deficient IgG to improve immune competence.
  • Immune thrombocytopenic purpura (ITP): raises platelet counts by modulating auto‑antibody activity.
  • Kawasaki disease: reduces fever and coronary artery inflammation in children.
  • Guillain‑Barré syndrome: accelerates recovery by providing anti‑inflammatory antibodies.

How It Works

  • Iqymune supplies a pooled preparation of human IgG antibodies that bind to pathogens, neutralise toxins, and modulate the immune system. The Fc portion of the infused IgG engages inhibitory Fcγ receptors, suppresses auto‑antibody production, and interferes with complement activation, thereby providing passive immunity and immunomodulatory effects.

Side Effects

Intravenous immunoglobulin therapy can be associated with a range of adverse reactions, from mild infusion‑related events to rare but serious complications.

Common Side Effects

  • Headache
  • Fever or chills
  • Nausea or vomiting
  • Fatigue or malaise
  • Mild infusion site reactions (redness, swelling)

Serious or Rare Side Effects

  • Anaphylactic or severe allergic reactions
  • Thromboembolic events (stroke, myocardial infarction)
  • Acute renal failure, especially with high‑osmolarity preparations
  • Aseptic meningitis
  • Hemolytic anemia
  • Severe thrombocytopenia

Precautions & Warnings

When using Iqymune, clinicians should observe several precautionary measures to minimise risks and ensure optimal therapeutic benefit.

  • Assess patient history: screen for IgA deficiency and previous severe reactions to immunoglobulins.
  • Monitor vital signs: observe blood pressure, temperature and respiratory status during infusion.
  • Adjust infusion rate: start slowly and increase gradually to reduce infusion‑related symptoms.
  • Review concomitant medications: anticoagulants and thrombotic risk factors may require dose modification.
  • Evaluate renal function: ensure adequate hydration and avoid nephrotoxic agents.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Human normal immunoglobulin can interact with other medicines, influencing efficacy or safety; awareness of key interactions guides safe co‑administration.

Major Interactions (Avoid)

  • Live vaccines: may be neutralised, reducing vaccine effectiveness.
  • High‑dose aspirin or other platelet inhibitors: increase risk of bleeding when combined with IVIG‑induced thrombocytopenia.

Moderate Interactions (Monitor Closely)

  • Anticoagulants (warfarin, DOACs): IVIG may enhance pro‑coagulant activity, requiring INR monitoring.
  • Immunosuppressants (cyclosporine, tacrolimus): may alter drug levels; monitor therapeutic concentrations.
  • Diuretics and nephrotoxic drugs: heightened risk of renal impairment; assess renal function regularly.

Frequently Asked Questions

Iqymune is a sterile intravenous immunoglobulin preparation used to replace deficient antibodies in patients with primary or secondary immunodeficiency, to modulate immune activity in autoimmune conditions such as immune thrombocytopenic purpura, and to treat inflammatory diseases like Kawasaki disease and Guillain‑Barré syndrome.

Human Normal Immunoglobulin provides a broad spectrum of pooled IgG antibodies that bind pathogens, neutralise toxins, and engage inhibitory Fcγ receptors. This action suppresses auto‑antibody production, modulates complement activation, and delivers passive immunity, helping to restore normal immune function.

The dose of Iqymune is individualized by the prescribing clinician based on the patient’s weight, the specific indication, and clinical response. Dosing regimens vary for primary immunodeficiency, autoimmune disorders, and acute inflammatory conditions, and are adjusted according to therapeutic goals and tolerability.

Data on the use of Iqymune in pregnancy and lactation are limited. It is generally prescribed only when the potential benefit to the mother outweighs any possible risk to the fetus or infant. Clinicians should discuss individual risk factors and consider alternative therapies when appropriate.

To order Iqymune, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain logistics) and any necessary import documentation.

Iqymune is comparable to other licensed IVIG preparations in terms of IgG content and clinical efficacy. Differences may exist in stabilisers, osmolarity, and manufacturing processes, which can influence infusion tolerability and specific safety profiles. Clinicians should review product monographs to select the preparation best suited to individual patient needs.

Iqymune must be stored refrigerated between 2 °C and 8 °C. Keep the vials in their original packaging, protect them from light, and avoid freezing or vigorous shaking. Before administration, allow the product to reach room temperature if required by the infusion protocol.

Iqymune is given by intravenous infusion under the supervision of a qualified healthcare professional. The infusion rate is typically started slowly and increased as tolerated. Monitoring of vital signs and observation for infusion reactions are standard practice throughout the administration period.

The most serious adverse events linked to Iqymune include severe allergic reactions such as anaphylaxis, thromboembolic complications (stroke, myocardial infarction), acute renal failure, aseptic meningitis, hemolytic anemia, and severe thrombocytopenia. Prompt recognition and management of these events are essential.

Iqymune is contraindicated in patients with a known severe IgA deficiency who have experienced anaphylaxis to blood products, and in individuals with a documented hypersensitivity to any component of the formulation. Caution is also advised for patients with uncontrolled hypercoagulable states or severe renal impairment.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Human Normal Immunoglobulin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT